Inflarx N Vis A Biopharmaceutical Company Based In Jenagermanyfounded In December 2007The Company Specializes In Developing Anti Inflammatory Therapeutics That Target The Complement Systemae S C5A C5Ar Pathwaywith Subsidiaries In Jenamunichand Ann Arbormichiganinflarx Focuses On Treating Acute And Chronic Inflammatory Diseases The Company Is Known For Its Proprietary Therapiesincluding Gohibicvilobelimab A First In Class Intravenous Monoclonal Antibody That Has Received Fda Emergency Use Authorization For Covid 19 Patients Requiring Invasive Mechanical Ventilationinflarx Is Also Developing Inf904An Oral Small Molecule C5A Receptor Inhibitor Aimed At Expanding Treatment Optionsthe Company Collaborates With Institutions Like Jena University Medical Center And The Beijing Institute Of Sciences To Enhance Its Research And Development Effortsinflarx Is Committed To Advancing Its Therapies And Has Recently Announced A Public Offering To Support Its Development Initiatives
| Company Name | Inflarx Gmbh |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
United States